MDCX

Pre-mercato: 2.72 0.04 +1.49%

Medicus Pharma Ltd (MDCX)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Medicus Pharma Ltd Stock (MDCX) Company Profile

Medicus Pharma Ltd

Healthcare (1052)

610-540-7515

300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN

Prossima data di guadagno

Ultimi documenti SEC

MDCX's Discussions on Twitter

Compare MDCX vs LLY, JNJ, ABBV, MRK, NVS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MDCX Medicus Pharma Ltd	2.68	3.84M	0	-28.53M	-20.10M	-1.7805
LLY Lilly Eli Co	1,270.75	1.13T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	257.78	621.22B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	284.80	503.28B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	149.88	369.78B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	153.93	292.58B	54.66B	13.58B	16.05B	7.0171

Medicus Pharma Ltd Borsa (MDCX) Ultime notizie

Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd Stock (MDCX) Company Profile

Compare MDCX vs LLY, JNJ, ABBV, MRK, NVS

Medicus Pharma Ltd Borsa (MDCX) Ultime notizie

Form PRE 14A MEDICUS PHARMA LTD. For: 19 October By Investing.com - Investing.com South Africa

Form PRE 14A MEDICUS PHARMA LTD. For: 19 October By Investing.com - Investing.com UK

409,411 directly owned shares are only part of an amended Medicus Pharma (MDCX) stake report. - Stock Titan

Medicus Pharma Warrant (MDCXW) Jumps 66.67% to $0.20 as Buyers Probe Upper RangePut Flow Alert - https://www.dars.gov.et/

The FDA authorized a planned skin-cancer study for people with a rare inherited condition. - Stock Titan

Medicus Pharma (MDCX) Shares Fall 24% After Hours: Here's Why - Benzinga

Medicus Pharma to implement 50-for-1 share consolidation to meet Nasdaq minimum bid - TradingView

Medicus Pharma to execute 50-to-1 reverse stock split on Oct. 12 - StreetInsider

Medicus Pharma Ltd. Warrant (MDCXW) Holds Flat at $0.35 Inside a Narrow Trading BandMACD Signal Stocks - https://www.dars.gov.et/

Medicus Pharma Warrant (MDCXW) Trades Flat at $0.35, Pinned Between $0.33 Support and $0.37 ResistanceProfit Surge Picks - https://www.siam.in/

Medicus Pharma Ltd. (MDCX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Dr. Raza Bokhari Discloses Investment at Medicus Pharma Ltd. with 5.3% Stake - TradingView

Medicus Pharma ends standby equity purchase agreement with Yorkville - Investing.com

How big is Medicus Pharma (MDCX) CEO Raza Bokhari's stake? - Stock Titan

MDCX 8-K FilingsMedicus Pharma Ltd. SEC 8-K - Stock Titan

FDA Clears Medicus SkinJect Study for Gorlin Syndrome - MyChesCo

Inside the deal: How a Montco biotech secured a Pfizer drug candidate - The Business Journals

Form 8K Medicus Pharma Ltd For: 11 September By Investing.com - Investing.com Nigeria

Medicus Pharma officers receive restricted shares in lieu of cash bonuses - Investing.com Nigeria

Medicus Pharma officers receive restricted shares in lieu of cash bonuses - Investing.com India

Medicus Pharma officers receive restricted shares in lieu of cash bonuses - Investing.com

Form 8K Medicus Pharma Ltd For: 11 September By Investing.com - Investing.com India

Medicus Pharma officers receive restricted shares in lieu of cash bonuses - Investing.com UK

Medicus Pharma officers receive restricted shares in lieu of cash bonuses - Investing.com

Medicus Pharma posts phase 2 study results for skin cancer drug By Investing.com - Investing.com Australia

Medicus Pharma officers receive restricted shares in lieu of cash bonuses By Investing.com - Investing.com South Africa

Medicus Pharma posts phase 2 study results for skin cancer drug - Investing.com Nigeria

Medicus Pharma secures Pfizer ADC deal, advances SkinJect and precision oncology strategy - Proactive financial news

Medicus Pharma secures Pfizer ADC deal, advances SkinJect and precision oncology strategy - Yahoo Finance

Medicus Pharma Identifies 200 µg SkinJect Patch as Lead Development Dose After Phase 2 Study - Yahoo Finance

Conshohocken's Medicus Pharma Picks Up a Discarded Pfizer Cancer Drug in a Deal Worth More Than $1 Billion - BioBuzz

Medicus Pharma posts phase 2 study results for skin cancer drug - Investing.com India

Medicus Pharma posts phase 2 study results for skin cancer drug - Investing.com Canada

Medicus Pharma Ltd. Posts Abridged Phase 2 Clinical Study Report for SkinJect® SKNJCT-003, Advances Gorlin Syndrome Development Plan - Quiver Quantitative

Medicus Pharma posts phase 2 study results for skin cancer drug - Investing.com UK

FDA authorizes the next study of a skin cancer patch - Stock Titan

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company - BioBuzz

Medicus Pharma reports positive Phase 2 data for SkinJect in skin cancer treatment - Proactive financial news

Medicus Pharma (MDCX) grants COO 735K shares and options - Stock Titan

Medicus Pharma (NASDAQ: MDCX) awards stock and options to its chief medical officer - stocktitan.net

Medicus Pharma (MDCX) hands CSO 588K shares and 100K options - stocktitan.net

Medicus Pharma (MDCX) CEO adds millions of shares and options in 2026 grant - Stock Titan

CFO adds Medicus Pharma (MDCX) stock and options - stocktitan.net

Medicus Pharma Prioritises CD228V Oncology Programme in Development Strategy - Yahoo Finance

Medicus Pharma shifts focus to precision oncology with CD228V By Investing.com - Investing.com Nigeria

Medicus Pharma shifts focus to precision oncology with CD228V - Investing.com

Medicus Pharma shifts focus to precision oncology with CD228V By Investing.com - Investing.com UK

Medicus Pharma Ltd. Repositions as Precision Oncology-Led Biotech, Prioritizes CD228V, SkinJect and Teverelix Programs - Quiver Quantitative

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company - Yahoo Finance

Medicus Pharma reorients around new cancer drug candidate, sharpens focus for other programs - Proactive financial news

Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a MDCX